-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Coverage Initiated by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Up 1.3 % Shares of BCLI stock opened at $1.60 on Friday. The firm’s fifty day simple moving […]
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Up 1.3 % Shares of BCLI stock opened at $1.60 on Friday. The firm’s fifty day simple moving […]
